Jonathan Monson - Boston Scientific Global VP

All Insiders . Brazil . 
Stock . Boston Scientific . Stakeholders . Insider . Jonathan Monson
B1SX34 Stock  BRL 554.58  11.78  2.17%   

Insider

Jonathan Monson is Global VP of Boston Scientific
Phone508 683 4000
Webhttps://www.bostonscientific.com

Boston Scientific Management Efficiency

The company has return on total asset (ROA) of 0.0425 % which means that it generated a profit of $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0407 %, meaning that it generated $0.0407 on every $100 dollars invested by stockholders. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities.
Boston Scientific has accumulated 8.79 B in total debt with debt to equity ratio (D/E) of 0.54, which is about average as compared to similar companies. Boston Scientific has a current ratio of 1.28, suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due. Debt can assist Boston Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Boston Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Boston Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Boston to invest in growth at high rates of return. When we think about Boston Scientific's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Emory WrightAlign Technology
53
Zelko RelicAlign Technology
58
Vandana VenkateshVerizon Communications
N/A
Luis VisosoUnity Software
54
Vamsi PudipeddiAlign Technology
51
Joseph HoganAlign Technology
66
Nicholas FrancisUnity Software
N/A
Mark BarrysmithUnity Software
51
Rashmi VasishtCognizant Technology Solutions
N/A
John MoriciAlign Technology
56
Rajesh MCACognizant Technology Solutions
55
Vittorio ColaoVerizon Communications
57
Shirley StacyAlign Technology
N/A
Joachim AnteUnity Software
41
John RiccitielloUnity Software
63
Anirma GuptaUnity Software
N/A
James GeraceVerizon Communications
59
Tamara ErwinVerizon Communications
58
Roxanne AustinVerizon Communications
58
Marc WhittenUnity Software
52
David HelgasonUnity Software
45
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. BOSTON SCIENDRN operates under Medical Devices classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 41000 people. Boston Scientific (B1SX34) is traded on Sao Paulo Exchange in Brazil and employs 10 people.

Management Performance

Return On Equity0.0407
Return On Asset0.0425

Boston Scientific Leadership Team

Elected by the shareholders, the Boston Scientific's board of directors comprises two types of representatives: Boston Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Boston. The board's role is to monitor Boston Scientific's management team and ensure that shareholders' interests are well served. Boston Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Boston Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jodi Eddy, VP Officer
Vance Brown, Gen VP
Catherine Jennings, VP Interventions
Joseph Fitzgerald, Ex Cardiology
John Sorenson, Ex Operations
Daniel Brennan, Ex CFO
Jeffrey Mirviss, Ex Interventions
Michael Mahoney, Pres Chairman
Jonathan Monson, Global VP
Susan Lisa, VP Relations

Boston Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Boston Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0407
Return On Asset0.0425
Profit Margin0.06 %
Operating Margin0.17 %
Current Valuation405.56 B
Shares Outstanding1.43 B
Price To Earning53.01 X
Price To Book3.82 X
Price To Sales28.55 X
Revenue11.89 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
CCitigroup
GMGeneral Motors
FFord Motor

Other Information on Investing in Boston Stock

Boston Scientific financial ratios help investors to determine whether Boston Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Scientific security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY